Alexion Pharmaceuticals (ALXN) PT Raised to $175 at Morgan Stanley; Robust Ultomiris Switch to Drive Stock Higher
Tweet Send to a Friend
(Updated - February 12, 2019 10:04 AM EST)(updated to add analyst comments)Morgan Stanley analyst Matthew Harrison raised the price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
